Other Therapy Areas

Extending our scientific depth across allergy, dermatology, ophthalmology, respiratory, women's health, and more.

Learn More →

    Home > endocrine-metabolic-disease Endocrine/Metabolic

    Therapeutic Areas

    Endocrine and Metabolic Disease

    Overcoming complexities to advance your endocrine and metabolic disease treatments to market rapidly

    Metabolic and endocrine diseases are a rising therapy area focus for clinical research due to the high demand for novel therapies that are challenged with proving safety and efficacy. At Veristat, we have assembled an extraordinary team of scientific-minded experts who have mastered the complexities of running metabolic disease trials. In the past five years, our team has supported 200+ projects for endocrine/metabolic disorder treatments and prepared nearly 40 marketing applications. 

    Developing endocrine or metabolic therapy? 

    Submit Your RFP     Talk to an Endocrine/Metabolic Expert

    Endocrine and Metabolic Disease Experience in the Past 5 Years

    +0

    clinical trials & consulting project supported

    0%

    in Rare/Ultra-Rare Indications

    ~0

    Marketing Applications Prepared

    Connect with an Endocrine/Metabolic Expert Today.

    We know there are always unknown challenges when bringing a novel therapeutics to market, so we’ve  assembled an extraordinary team of scientific minded experts who have mastered the complexities of therapeutic development enabling sponsors to succeed in extending and saving lives.

    Home > endocrine-metabolic-disease Endocrine/Metabolic

    Experience in Taking on Endocrine and Metabolic Disease Clinical Trials

    Whether you are aiming to combat a thyroid, inherited, or reproductive disorder, Veristat can help make a difference in your study’s success. Our teams understand the nuances and difficulties involved with treating endocrine and metabolic diseases, including experience executing type 1 and 2 diabetes trials. 

    Veristat’s experts are poised to plan and launch your trials quickly providing: 

    Home > endocrine-metabolic-disease Endocrine/Metabolic
    Home > endocrine-metabolic-disease Endocrine/Metabolic

    HubDB_Card Image_Flexibility Drives Progress

     

    Case Study: Flexibility Drives Progress During a Rare Disease Gene Therapy Clinical Trial 

    Veristat was engaged by a biotech organization focusing on gene therapies for metabolic diseases to support their clinical study for the treatment of a rare human genetic lysosomal storage disorder. Through a collaborative partnership and a flexible operating model, we addressed critical patient, lab, product manufacturing, logistics, and tracking/reporting requirements to satisfy our Sponsor’s requirements at every milestone.   

    Read Case Study 

    Home > endocrine-metabolic-disease Endocrine/Metabolic

    Scientific Excellence Across Endocrine & Metabolic Disease Indications 

    Common Indications

    • Diabetes (Type 1 and 2) 
    • Menopause 
    • NASH
    • Obesity 
    • Polycystic Ovary Syndrome 
    • and more...
    Common Endocrine and Metabolic Disease Indications

    Rare Indications

    • Adrenoleukodystrophy 
      Bardet-Biedl Syndrome 
      Fabry Disease 
      Gaucher Disease 
      Lysosomal Acid Lipase Deficiency 
      Pompe Disease 
      and many more... 
    rare endocrine metabolic disease indications

    Pediatric Indications


    • Cerebral Adrenoleukodystrophy 
    • Duchenne Muscular Dystrophy
      Limb-girdle Muscular Dystrophy
      Myotonic Dystrophy
      X-linked Myotubular Myopathy

      and more...
    pediatric endocrine metabolic disease indications
    I would like to thank the entire team at Veristat, who worked day and night to submit our DSUR and our IND within thirty days of starting to work with us!

    In addition to managing the process, the team worked seamlessly with us in the United States and our partner in Korea. Your team advised and guided us to produce quality submissions to meet our challenging corporate goal of submitting both on time. Due to these extraordinary efforts, we plan to work with you on our second IND submission.
    CEO
    Clinical Stage Biotechnology Company

    Learn More with These Resources

    Infographic

    A Practical Guide for Managing Multiple Global Regulatory ...

    Infographic

    FDA Expedited Programs – What You Need to Know

    Fact Sheet

    Side-by-Side Comparison: Non-Adaptive vs. Adaptive Designs in ...